METABOLISM RESEARCH PUBLICATIONS OF 2022

• Balderas E, Eberhardt DR, Lee S, Pleinis JM, Sommakia S, Balynas AM, Yin X, Parker MC, Maguire CT, Cho S, Szulik MW, Bakhtina A, Bia RD, Friederich MW, Locke TM, Van Hove JLK, Drakos SG, Sancak Y, Tristani-Firouzi M, Franklin S, Rodan AR, Chaudhuri D. Mitochondrial calcium uniporter stabilization preserves energetic homeostasis during Complex I impairment. Nat. Commun., 2022.
• Shimura D, Hunter J, Katsumara M, Shaw RM. Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein. JoVE 2022;March 16: doi: 10.3791/63405.
• Eberhardt DR, Lee SH, Yin X, Balynas AM, Rekate E, Kraiss JN, Lang MJ, Walsh MA, Streiff ME, Corbin AC, Funai K, Sachse FB, Chaudhuri D. EFHD1 ablation inhibits cardiac mitoflash activation and protects cardiomyocytes from ischemia. J Mol Cell Cardiol. 2022. doi: 10.1016/j.yjmcc.2022.03.002. PMID: 35304170
• Sommakia, S., N.H. Almaw, S.H. Lee, D.K.A. Ramadurai, I. Taleb, C.P. Kyriakopoulos, C.J. Stubben, J. Ling, R.A. Campbell, R.A. Alharethi, W.T. Caine, S. Navankasattusas, G.L. Hoareau, A.E. Abraham, J.C. Fang, C.H. Selzman, S.G. Drakos, and D. Chaudhuri, FGF21 (Fibroblast Growth Factor 21) Defines a Potential Cardiohepatic Signaling Circuit in End-Stage Heart Failure. Circ Heart Fail, 2022. 15(3): p. e008910, PMC8930477, PMID 34865514